We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Not so manic Monday

28 September 2009 By Robert Cyran

Against some ambitious recent deals, the US healthcare company’s purchase of the Belgian chemical group s drug arm looks boringly sensible. At two times sales, the price is right. It s better than leaving the cash sitting in overseas banks, too.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)